Dato Pharma And Engineering Private Limited - Company Profile

It is a industrial manufacturing private limited company based in New Delhi, Delhi, India, established in 2010.
2010 New Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Dato Pharma And Engineering Private Limited

Dato Pharma And Engineering Private Limited, a struck off private limited company, was established on 09 March 2010 in New Delhi, Delhi, India. Engaging in manufacturing within the industrial manufacturing sector, it holds CIN: U29220DL2010PTC199864. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Akshay Kumar (Director), Varsha Rani (Director). It is based at 239, Sfs Flat, Golden Jublee Apartment Sector - 11, Rohini, New Delhi, Delhi, 110085.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U29220DL2010PTC199864

  • Registration Number

    199864

  • Incorporation Date

    09 March 2010

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 16 Year, 2 Months
Company report

Dato Pharma And Engineering Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Dato Pharma And Engineering Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Dato Pharma And Engineering Private Limited?
Current Directors
Name Designation Appointment Date Status
Akshay Kumar Director 09 Mar 2010 Current
Varsha Rani Director 09 Mar 2010 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dato Pharma And Engineering.

Enhance accessibility to Dato Pharma And Engineering's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Dato Pharma And Engineering revenue growth over time
Dato Pharma And Engineering profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dato Pharma And Engineering?

Unlock access to Dato Pharma And Engineering's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Dato Pharma And Engineering?

Unlock and access historical data on people associated with Dato Pharma And Engineering, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dato Pharma And Engineering, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dato Pharma And Engineering's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dato Pharma And Engineering
Recent Activity within the Organization
  • Director Appointment

    The activity Akshay Kumar was appointed as a Director was appointed as a Director on 09 Mar 2010 & has been associated with this company since 16 years 2 months . was completed.

  • Director Appointment

    The activity Varsha Rani was appointed as a Director was appointed as a Director on 09 Mar 2010 & has been associated with this company since 16 years 2 months . was completed.

  • Company Incorporation

    Progress on Dato Pharma And Engineering Private Limited was registered on 09 Mar 2010 with Roc Delhi & aged 16 years 2 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dato Pharma And Engineering Private Limited?

The CIN of Dato Pharma And Engineering Private Limited is U29220DL2010PTC199864.

Where is Dato Pharma And Engineering Private Limited headquartered?

Dato Pharma And Engineering Private Limited is headquartered at 239, Sfs Flat, Golden Jublee Apartment Sector - 11, Rohini, New Delhi, Delhi, 110085.

When was Dato Pharma And Engineering Private Limited incorporated?

Dato Pharma And Engineering Private Limited was incorporated on 09 March 2010.

Who are the current directors of Dato Pharma And Engineering Private Limited?

The current directors of Dato Pharma And Engineering Private Limited are

What is the primary industry of Dato Pharma And Engineering Private Limited?

The primary industry of Dato Pharma And Engineering Private Limited is Industrial Manufacturing.

Is Dato Pharma And Engineering Private Limited a listed company?

Dato Pharma And Engineering Private Limited is unlisted.

What is the capital structure of Dato Pharma And Engineering Private Limited?

The authorized capital of Dato Pharma And Engineering Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available